Sulforaphane Cannot Protect Human Fibroblasts From Repeated, Short and Sublethal Treatments with Hydrogen Peroxide.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
23 02 2019
Historique:
received: 13 01 2019
revised: 17 02 2019
accepted: 18 02 2019
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 27 6 2019
Statut: epublish

Résumé

A delicate balance of reactive oxygen species (ROS) exists inside the cell: when the mechanisms that control the level of ROS fail, the cell is in an oxidative stress state, a condition that can accelerate aging processes. To contrast the pro-aging effect of ROS, the supplementation of antioxidants has been recently proposed. Sulforaphane (SFN) is an isothiocyanate isolated from Brassica plants that has been shown to modulate many critical factors inside the cells helping to counteract aging processes. In the present work, we exposed human dermal fibroblast to short, sublethal and repeated treatments with hydrogen peroxide for eight days, without or in combination with low concentration of SFN. Hydrogen peroxide treatments did not affect the oxidative status of the cells, without any significant change of the intracellular ROS levels or the number of mitochondria or thiols in total proteins. However, our regime promoted cell cycle progression and cell viability, increased the anti-apoptotic factor survivin and increased DNA damage, measured as number of foci positive for γ -H2AX. On the other hand, the treatment with SFN alone seemed to exert a protective effect, increasing the level of p53, which can block the expansion of possible DNA damaged cells. However, continued exposure to SFN at this concentration could not protect the cells from stress induced by hydrogen peroxide.

Identifiants

pubmed: 30813396
pii: ijerph16040657
doi: 10.3390/ijerph16040657
pmc: PMC6406632
pii:
doi:

Substances chimiques

Antioxidants 0
Isothiocyanates 0
Sulfoxides 0
Hydrogen Peroxide BBX060AN9V
sulforaphane GA49J4310U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Free Radic Biol Med. 2009 Sep 15;47(6):675-83
pubmed: 19527783
Curr Top Cell Regul. 2000;36:151-80
pubmed: 10842751
PLoS One. 2012;7(2):e32117
pubmed: 22359661
Aging Cell. 2015 Feb;14(1):78-91
pubmed: 25510262
Proc Natl Acad Sci U S A. 2011 May 31;108(22):8990-5
pubmed: 21576488
Free Radic Biol Med. 2012 Aug 15;53(4):907-15
pubmed: 22732185
Anal Biochem. 2014 Dec 15;467:1-3
pubmed: 25193447
Redox Biol. 2014;2:165-9
pubmed: 25460727
Mech Ageing Dev. 1998 Sep 15;105(1-2):137-50
pubmed: 9922124
J Cell Mol Med. 2009 Sep;13(9B):3131-40
pubmed: 18624771
Free Radic Biol Med. 2015 Dec;89:443-51
pubmed: 26453922
Annu Rev Biochem. 2017 Jun 20;86:715-748
pubmed: 28441057
Cancer Res. 2002 Sep 15;62(18):5196-203
pubmed: 12234984
Cell Physiol Biochem. 2001;11(4):173-86
pubmed: 11509825
Top Curr Chem. 2013;329:163-77
pubmed: 22752583
Adv Exp Med Biol. 2014;773:415-30
pubmed: 24563359
Vascul Pharmacol. 2013 Jul-Aug;59(1-2):44-51
pubmed: 23810908
Science. 2012 Jun 15;336(6087):1440-4
pubmed: 22700930
Sci Rep. 2017 Mar 03;7:43669
pubmed: 28255164
Mol Cell. 2008 May 9;30(3):277-89
pubmed: 18471974
Oncogene. 2017 Nov 2;36(44):6204-6212
pubmed: 28692050
Mol Biol Cell. 2006 Apr;17(4):1758-67
pubmed: 16436511
Oxid Med Cell Longev. 2016;2016:3565127
pubmed: 27247702
Free Radic Biol Med. 2011 Jul 15;51(2):327-36
pubmed: 21619928
Dose Response. 2014 Jan 31;12(2):288-341
pubmed: 24910588
Bio Protoc. 2016 Nov 5;6(21):
pubmed: 28573164
EMBO J. 2000 Dec 1;19(23):6517-26
pubmed: 11101524
Cancer Lett. 2017 May 28;394:52-64
pubmed: 28254410
Crit Rev Food Sci Nutr. 2018 May 24;58(8):1391-1405
pubmed: 28001083
Clin Sci (Lond). 2015 May 1;128(10):635-48
pubmed: 25760962
Age (Dordr). 2012 Apr;34(2):281-93
pubmed: 21465338
Biochem J. 2000 Jun 1;348 Pt 2:425-32
pubmed: 10816438
Evid Based Complement Alternat Med. 2013;2013:135314
pubmed: 23662110
J Ovarian Res. 2013 Jun 26;6(1):41
pubmed: 23799914
Mol Med Rep. 2017 Nov;16(5):7796-7804
pubmed: 28944886
Nestle Nutr Inst Workshop Ser. 2015;83:11-8
pubmed: 26485647
Anal Cell Pathol. 1998;17(2):103-10
pubmed: 10052634
Mol Cell. 2013 Aug 8;51(3):374-85
pubmed: 23871434
Clin Exp Dermatol. 2016 Jun;41(4):417-24
pubmed: 26899383
Exp Dermatol. 2010 Feb;19(2):137-44
pubmed: 19558496
Pol J Pharmacol. 2002 May-Jun;54(3):215-23
pubmed: 12398152
Free Radic Biol Med. 2013 Feb;55:109-18
pubmed: 23142766

Auteurs

Maria Chiara Lionetti (MC)

Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, via Celoria 26, 20133 Milano, Italy. maria.lionetti@unimi.it.

Federico Mutti (F)

Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, via Celoria 26, 20133 Milano, Italy. federicomutti92@gmail.com.

Erica Soldati (E)

Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, via Celoria 26, 20133 Milano, Italy. ericasoldati92@gmail.it.

Maria Rita Fumagalli (MR)

Center for Complexity and Biosystems, Department of Physics, University of Milan, via Celoria 16, 20133 Milano, Italy. maria.fumagalli@unimi.it.

Valentina Coccé (V)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Via Pascal 36, 20133 Milano, Italy. valentina.cocce@guest.unimi.it.

Graziano Colombo (G)

Department of Biosciences, University of Milan, via Celoria 26, 20133 Milano, Italy. graziano.colombo@unimi.it.

Emanuela Astori (E)

Department of Biosciences, University of Milan, via Celoria 26, 20133 Milano, Italy. emanuela.astori@unimi.it.

Alessandro Miani (A)

Department of Environmental Science and Policy, University of Milan, via Celoria 10, 20133 Milano, Italy. alessandro.miani@unimi.it.
SIMA, Societá Italiana di Medicina Ambientale, via Monte Leone 2, 20149 Milano, Italy. alessandro.miani@unimi.it.

Aldo Milzani (A)

Department of Biosciences, University of Milan, via Celoria 26, 20133 Milano, Italy. aldo.milzani@unimi.it.

Isabella Dalle-Donne (I)

Department of Biosciences, University of Milan, via Celoria 26, 20133 Milano, Italy. isabella.dalledonne@unimi.it.

Emilio Ciusani (E)

Fondazione IRCCS Istituto Neurologico C. Besta, Via Celoria 11, 20133 Milano, Italy. emilio.ciusani@istituto-besta.it.

Giulio Costantini (G)

Center for Complexity and Biosystems, Department of Physics, University of Milan, via Celoria 16, 20133 Milano, Italy. gr.costantini@gmail.com.

Caterina A M La Porta (CAM)

Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, via Celoria 26, 20133 Milano, Italy. caterina.laporta@unimi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH